Reeder-Hayes KE - Search Results

1

Chemotherapy and Targeted Therapy for Patients With Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer That is Either Endocrine-Pretreated or Hormone Receptor-Negative: ASCO Guideline Update.

Moy B, Rumble RB, Come SE, Davidson NE, Di Leo A, Gralow JR, Hortobagyi GN, Yee D, Smith IE, Chavez-MacGregor M, Nanda R, McArthur HL, Spring L, Reeder-Hayes KE, Ruddy KJ, Unger PS, Vinayak S, Irvin WJ Jr, Armaghani A, Danso MA, Dickson N, Turner SS, Perkins CL, Carey LA. Moy B, et al. J Clin Oncol. 2021 Dec 10;39(35):3938-3958. doi: 10.1200/JCO.21.01374. Epub 2021 Jul 29. J Clin Oncol. 2021. PMID: 34324366

2

Clinical trials in triple negative breast cancer.

Reeder-Hayes KE, Carey LA, Sikov WM. Reeder-Hayes KE, et al. Breast Dis. 2010;32(1-2):123-36. doi: 10.3233/BD-2010-0310. Breast Dis. 2010. PMID: 21778571 Review.

3

Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research.

Wheeler SB, Reeder-Hayes KE, Carey LA. Wheeler SB, et al. Oncologist. 2013;18(9):986-93. doi: 10.1634/theoncologist.2013-0243. Epub 2013 Aug 12. Oncologist. 2013. PMID: 23939284 Free PMC article.

4

How low should we go? The search for balance in management of small human epidermal growth factor receptor 2-positive breast cancers.

Reeder-Hayes KE, Carey LA. Reeder-Hayes KE, et al. J Clin Oncol. 2014 Jul 10;32(20):2122-4. doi: 10.1200/JCO.2014.55.7249. Epub 2014 Jun 2. J Clin Oncol. 2014. PMID: 24888811 No abstract available.

5

Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing.

Roberts MC, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes KE, Troester MA, Carey LA, Wheeler SB. Roberts MC, et al. Breast Cancer Res Treat. 2015 Aug;153(1):191-200. doi: 10.1007/s10549-015-3518-9. Epub 2015 Jul 28. Breast Cancer Res Treat. 2015. PMID: 26216535 Free PMC article.

6

Racial Variation in the Uptake of Oncotype DX Testing for Early-Stage Breast Cancer.

Roberts MC, Weinberger M, Dusetzina SB, Dinan MA, Reeder-Hayes KE, Carey LA, Troester MA, Wheeler SB. Roberts MC, et al. J Clin Oncol. 2016 Jan 10;34(2):130-8. doi: 10.1200/JCO.2015.63.2489. Epub 2015 Nov 23. J Clin Oncol. 2016. PMID: 26598755 Free PMC article.

7

Disparities in Use of Human Epidermal Growth Hormone Receptor 2-Targeted Therapy for Early-Stage Breast Cancer.

Reeder-Hayes K, Peacock Hinton S, Meng K, Carey LA, Dusetzina SB. Reeder-Hayes K, et al. J Clin Oncol. 2016 Jun 10;34(17):2003-9. doi: 10.1200/JCO.2015.65.8716. Epub 2016 Apr 11. J Clin Oncol. 2016. PMID: 27069085 Free PMC article.

8

Haunted.

Reeder-Hayes KE. Reeder-Hayes KE. J Clin Oncol. 2017 Jan;35(1):113-114. doi: 10.1200/JCO.2016.70.7273. Epub 2016 Nov 14. J Clin Oncol. 2017. PMID: 28034072 No abstract available.

9

Comparative Toxicity and Effectiveness of Trastuzumab-Based Chemotherapy Regimens in Older Women With Early-Stage Breast Cancer.

Reeder-Hayes KE, Meyer AM, Hinton SP, Meng K, Carey LA, Dusetzina SB. Reeder-Hayes KE, et al. J Clin Oncol. 2017 Oct 10;35(29):3298-3305. doi: 10.1200/JCO.2016.71.4345. Epub 2017 Jul 20. J Clin Oncol. 2017. PMID: 28727517 Free PMC article.

10

Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study.

Troester MA, Sun X, Allott EH, Geradts J, Cohen SM, Tse CK, Kirk EL, Thorne LB, Mathews M, Li Y, Hu Z, Robinson WR, Hoadley KA, Olopade OI, Reeder-Hayes KE, Earp HS, Olshan AF, Carey LA, Perou CM. Troester MA, et al. J Natl Cancer Inst. 2018 Feb 1;110(2):176-82. doi: 10.1093/jnci/djx135. J Natl Cancer Inst. 2018. PMID: 28859290 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

131 results

Search Page